Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2019 Sep 6;12(9):e230948.
doi: 10.1136/bcr-2019-230948.

Interstitial pneumonia with autoimmune features and platypnea-orthopnea syndrome

Affiliations
Case Reports

Interstitial pneumonia with autoimmune features and platypnea-orthopnea syndrome

Uthara Mathew et al. BMJ Case Rep. .

Abstract

Interstitial pneumonia with autoimmune features (IPAF) is a recently proposed terminology for interstitial lung disease (ILD) with evidence of autoimmunity that does not meet the criteria for a defined connective tissue disease (CTD). Although ILD is well recognised in patients with established CTD, it is rarely the sole presenting feature of CTD. We report a case of 22-year-old male patient, who presented with progressive shortness of breath for 2 months and had features suggestive of platypnea-orthodeoxia syndrome (POS). Imaging revealed ILD with usual interstitial pneumonia pattern. Patient had features of autoimmune disorder but did not fulfil the criteria for any CTD and hence was labelled as IPAF. His POS was attributed predominantly to the lower lobe disease. The patient responded well to immunosuppressive treatment. A systematic review of literature of all cases with POS due to pulmonary parenchymal involvement has also been done.

Keywords: connective tissue disease; interstitial lung disease; statistics and research methods.

PubMed Disclaimer

Conflict of interest statement

Competing interests: None declared.

Figures

Figure 1
Figure 1
(A and B) Lung window and high resolution (HR) window showing reticular abnormalities with mild ground-glass opacification and traction bronchiectasis with predominant basal and subpleural distribution, respectively. (C and D) Lung window and HR window showing resolution of the reticular opacities.
Figure 2
Figure 2
Study selection flowchart.

References

    1. Fischer A, Antoniou KM, Brown KK, et al. “ERS/ATS Task Force on Undifferentiated Forms of CTD-ILD”. An official European Respiratory Society/American Thoracic Society research statement: interstitial pneumonia with autoimmune features. Eur Respir J 2015;46:976–87. - PubMed
    1. Sambataro G, Sambataro D, Torrisi SE, et al. State of the art in interstitial pneumonia with autoimmune features: a systematic review on retrospective studies and suggestions for further advances. Eur Respir Rev 2018;27:170139 10.1183/16000617.0139-2017 - DOI - PMC - PubMed
    1. Dai J, Wang L, Yan X, et al. Clinical features, risk factors, and outcomes of patients with interstitial pneumonia with autoimmune features: a population-based study. Clin Rheumatol 2018;37:2125–32. 10.1007/s10067-018-4111-5 - DOI - PubMed
    1. Kelly BT, Moua T. Overlap of interstitial pneumonia with autoimmune features with undifferentiated connective tissue disease and contribution of UIP to mortality. Respirology 2018;23:600–5. 10.1111/resp.13254 - DOI - PubMed
    1. Vij R, Noth I, Strek ME. Autoimmune-featured interstitial lung disease: a distinct entity. Chest 2011;140:1292–9. 10.1378/chest.10-2662 - DOI - PMC - PubMed

Publication types

MeSH terms

Substances